281 related articles for article (PubMed ID: 24097557)
1. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
2. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
[TBL] [Abstract][Full Text] [Related]
4. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.
Day BJ; van Heeckeren AM; Min E; Velsor LW
Infect Immun; 2004 Apr; 72(4):2045-51. PubMed ID: 15039325
[TBL] [Abstract][Full Text] [Related]
5.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
6. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
[TBL] [Abstract][Full Text] [Related]
8. Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent.
Munder A; Wölbeling F; Kerber-Momot T; Wedekind D; Baumann U; Gulbins E; Tümmler B
Respir Res; 2011 Nov; 12(1):148. PubMed ID: 22059807
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
12. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
[TBL] [Abstract][Full Text] [Related]
13. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
14. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
15. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.
van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge.
Rosenjack J; Hodges CA; Darrah RJ; Kelley TJ
Sci Rep; 2019 Jul; 9(1):10282. PubMed ID: 31311988
[TBL] [Abstract][Full Text] [Related]
17. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.
van Heeckeren AM; Schluchter MD; Xue W; Davis PB
Am J Respir Crit Care Med; 2006 Feb; 173(3):288-96. PubMed ID: 16272448
[TBL] [Abstract][Full Text] [Related]
18. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
[TBL] [Abstract][Full Text] [Related]
20. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.
Parker D; Cohen TS; Alhede M; Harfenist BS; Martin FJ; Prince A
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):6-13. PubMed ID: 21778412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
